It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade

J Formos Med Assoc. 2021 Jan;120(1 Pt 1):1-4. doi: 10.1016/j.jfma.2020.07.009. Epub 2020 Jul 11.
No abstract available

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Humans
  • Immune Checkpoint Inhibitors
  • Immunotherapy
  • Liver Neoplasms* / drug therapy
  • Programmed Cell Death 1 Receptor

Substances

  • Immune Checkpoint Inhibitors
  • Programmed Cell Death 1 Receptor